Product Reports Resources Pricing Login Book a demo

Penumbra

Biotech & Life Sciences · Alameda, United States · Founded 2004 · IPO 2015

Penumbra develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases

Valuation $12B
Revenue $1.60B
EBITDA $286M
Power Law Decacorn$10B+ valuation tier Thoroughbred$100M+ revenue

Talent graph

Penumbra's talent

Book a demo to see the people
Employees mapped 3,171 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 25 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on Penumbra's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
Fidelity Investments

Penumbra mafia

Startups founded by Penumbra alumni

Former Penumbra employees who went on to start their own companies. Sorted by Dealroom signal score.

CollateEst. 2025
Surbhi SarnaUnited States
Signal score95
Sans Strings StudioEst. 2023
Ryan CornielUnited States
Signal score84
Persist AIEst. 2022
Karthik Raman, PhDUnited States
Signal score70
Interline TherapeuticsEst. 2020
MLMatt LuminaisUnited States
Signal score60

Book a demo to explore the full alumni network →

Global footprint

Where Penumbra has talent and traffic

Workforce by country
37 countries with
team presence
🇺🇸 United States85.7%
🇩🇪 Germany3%
🇮🇹 Italy1.5%
🇵🇱 Poland0.9%
🇬🇧 United Kingdom0.8%
Top 5 of 37 shown
Web traffic by country
43K monthly visits
across markets
🇺🇸 United States40.2%
🏳️ Korea10.9%
🏳️ Republic of9.5%
🇦🇺 Australia6.7%
🇨🇦 Canada5.6%
Top 5 markets shown

Patent intelligence

Penumbra’s patent portfolio

Estimated portfolio value
$22M

45 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Market sentiment

What the market is saying about Penumbra

An AI-synthesized read of the highest-engagement posts about Penumbra on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Penumbra on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles